Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management
Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 9, pp. 2893-2910
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
Stanley I.R. Okoduwa, Ibrahim Abdulwaliyu, Bernard E. Igiri, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100558-100558
Open Access | Times Cited: 10
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series
Nelson Luis Cahuapaza-Gutierrez
Lupus (2024) Vol. 33, Iss. 4, pp. 375-386
Closed Access | Times Cited: 6
COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data
Tuba Demirci Yıldırım, Cansu Akleylek, Derya Yıldırım, et al.
Asian Pacific Journal of Tropical Medicine (2025) Vol. 18, Iss. 2, pp. 77-83
Open Access
Pediatric Systemic Lupus Erythematous in COVID-19 Era
Ancuța Lupu, Ingrith Miron, Cristina Gavrilovici, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 272-272
Open Access | Times Cited: 14
Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment
Kyriakos A. Kirou, Maria Dall’Era, Cynthia Aranow, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Systemic Lupus Erythematosus and COVID-19
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 11
Long noncoding RNA SNHG16 regulates TLR4-mediated autophagy and NETosis formation in alveolar hemorrhage associated with systemic lupus erythematosus
Yu-Tung Hsieh, Yi‐Cheng Chen, Yu‐Chi Chou, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 7
Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey
R. Moraliyska, Tsvetoslav Georgiev, Simona Bogdanova, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 165-172
Closed Access | Times Cited: 7
A Framework to Overcome Challenges in the Management of Infections in Patients with Systemic Lupus Erythematosus
M. S. Rao, Jamal Mikdashi
Open Access Rheumatology Research and Reviews (2023) Vol. Volume 15, pp. 125-137
Open Access | Times Cited: 6
The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
Yan Geng, Yong Fan, Xuerong Deng, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 4, pp. 1039-1053
Open Access | Times Cited: 5
COVID-19 and SLE: Infection and autoimmunity at its best
Naim Mahroum, Abdulrahman Elsalti, Mehmet Fatih Ozkan, et al.
Lupus (2023) Vol. 32, Iss. 14, pp. 1591-1597
Closed Access | Times Cited: 5
A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2
Ernesto Zavala-Flores, Jannin Salcedo-Matienzo, Roberto Huamanchumo-Guzman, et al.
Lupus (2024) Vol. 33, Iss. 3, pp. 282-288
Closed Access | Times Cited: 1
Distinct Clinical Manifestations of COVID-19 in Multiple Sclerosis Patients: Unraveling the Clinical Nexus
Amir Aboofazeli, Mozhgan Mondeali, Roxana Tajdini, et al.
Archives of Neuroscience (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Successful management of belimumab after obinutuzumab in a patient with systemic lupus erythematosus: a case report with an 18-month follow-up
Xiuxiu Pu, Qiao Ye, Lin Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Case report: Unusual patient with dermatomyositis associated with SARS-CoV-2 infection
Joanna Niedzielska, Monika Chaszczewska-Markowska, Justyna Chojdak-Łukasiewicz, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register
Joana Starling de Carvalho, Edgard Torres dos Reis Neto, Adriana María Kakehasi, et al.
Lupus (2022) Vol. 32, Iss. 1, pp. 42-53
Open Access | Times Cited: 5
Onset or flare of systemic lupus erythematosus preceded by severe acute respiratory syndrome coronavirus 2 infection
Chrong‐Reen Wang, Wei-Chieh Lin
Journal of the Formosan Medical Association (2023) Vol. 123, Iss. 1, pp. 133-135
Open Access | Times Cited: 2
Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis
Anum Akhlaq, Sameen Aamer, Khawaja Muthammir Hasan, et al.
Lupus (2024) Vol. 33, Iss. 3, pp. 248-254
Closed Access
Effect of the COVID-19 on Patients with Systemic Lupus Erythematosus during the First Pandemic Wave in China
Pengjia Wu, Xiaoxia Liu, Na Li, et al.
Research Square (Research Square) (2024)
Open Access
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access
Lúpus eritematoso sistêmico e COVID-19: uma revisão integrativa
Amanda Chelala Silveira, Gabriel Sampaio Monteiro, Livia Catarina Lopes Vianna Couto, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e72060-e72060
Open Access
COVID‐19 Vaccination in Patients With Systemic Lupus Erythematosus: Adverse Events and Rating Agreement of Flares Between Patients and Physicians
Punsita Tangkum, Nuntana Kasitanon, Wanitcha Gumtorntip, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 12
Closed Access
Flares and Predicting Factors of Flares in Patients with Systemic Lupus Erythematosus Associated with Different Doses and Types of COVID-19 Vaccines
Worawit Louthrenoo, Punsita Tangkum, Nuntana Kasitanon, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1399-1399
Open Access
Fatal COVID-19 Pneumonia in a Rheumatoid Arthritis Patient Receiving Long-Term Rituximab Therapy
Chrong‐Reen Wang, Wei-Chieh Lin
Annals of Pharmacotherapy (2022) Vol. 57, Iss. 5, pp. 617-619
Open Access | Times Cited: 3
Central Nervous System Neuroimmunologic Complications of COVID-19
Kathryn B. Holroyd, Sarah Conway
Seminars in Neurology (2023) Vol. 43, Iss. 02, pp. 229-250
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top